TYK2 inhibitors

JP2026520505APending Publication Date: 2026-06-23NUMERION LOVES INC

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: JP · JP
Patent Type: Applications
Current Assignee / Owner: NUMERION LOVES INC
Filing Date: 2024-06-03
Publication Date: 2026-06-23

Application Information

Patent Timeline

03 Jun 2024

Application

23 Jun 2026

Publication

JP2026520505A

IPC: C07D491/107; A61P43/00; A61P37/06; A61P17/06; A61P19/02; A61P1/04; A61K31/506; C07D401/14; C07D405/14; C07D491/048; C07D401/12; A61K31/5377; C07D403/12; C07D413/14; C07D239/48; A61K31/505

CPC: C07D491/107; A61P37/02; C07D413/14; C07D401/12; C07D401/14; A61P1/00; A61K31/675; A61P17/06

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Smart Images

Figure 2026520505000152
Figure 2026520505000153
Figure 2026520505000154

Patent Text Reader

Abstract

Exemplary embodiments provide tyrosine kinase 2 (TYK2) inhibitors, pharmaceutical formulations comprising these compounds, and methods for using these compounds to inhibit TYK2 and treat diseases such as autoimmune and inflammatory diseases.

Need to check novelty before this filing date? Find Prior Art